Wearables and Telemedicine: Longevity Medicine’s Front Line.

I love my WHOOP MG.

When my alarm goes off each morning, the first thing that I do is open the WHOOP app and push “end sleep.” At that point, with anticipation, I wait the 10-15 seconds that it typically takes to generate my sleep score and overnight recovery. I cannot lie: I feel validation when the middle circle is green, showing strong “Recovery.”  And I admit that I feel some disappointment with yellow, or even red.

(My real scores on June 5, 2026). 

After caffeine, supplements, and breakfast, I head to my home gym. Monday-Wednesday-Friday – I lift heavy.  Tuesday-Thursday Zone 2 cardio.  Saturdays alternate between Zone 2 cardio, ancillary lifting, or (gasp) a day off.  Sundays are for intense Zone 4-5 HIIT training.   

When I exercise – especially when I do cardio – I project the app onto a television screen and track my heart rate in real time. I adjust my pace on a treadmill, or my incline, to maintain my heart rate in as narrow ranges as possible, depending on my target. 

Zone 2 – A Tuesday in May 2028

Zone 4-5 – a Sunday in May 2026

I also update my lab results into the WHOOP, allowing it to factor this information into the overall picture (WHOOP has an integration to order labs through the app, but I do this externally and manually upload.)

Each Sunday morning I wake up to my weekly “WHOOP Age” update. The age and pace of aging update weekly based on how much weightlifting I have done, how much Zone 2 cardio, how much high-intensity cardio, how much sleep I have gotten, how consistent my sleep has been, and other components.  The factors themselves are no secret: WHOOP encourages me – at least subtly – to address certain of the factors to improve my scores. 

(“Real” WHOOP Age as of June 5, 2026 as compared to biological age of 46). 

On a daily basis, I find myself interacting with my WHOOP.  Receiving reams of information, but also adding my own feedback. I tell it if I am injured or fatigued. I upload my labs or imaging into it. I ask it all sorts of questions. And since I never take it off, I maintain baselines of biometric data across almost all activities for months and months in a row. 

Any primary care provider that I trust must consider this data valuable. If a doctor tells me this is all just fluff, noise, or a distraction, I look for a new doctor.  Because in my view this is the future of medicine. 

For most of medical history, healthcare has been episodic — you feel sick, you see a doctor, you go home. The data gathered during that encounter — a blood pressure reading, a resting heart rate, a snapshot spirometry — tells your physician almost nothing about the 8,764 other hours in the year.  

After the Affordable Care Act, annual (i.e. 1x per year) wellness visits were covered automatically as an Essential Health Benefit.  Now that seems quaint. 

The convergence of consumer wearable technology and telemedicine is rewriting what continuous, personalized healthcare can look like. Real-time biometrics, AI integration, telehealth integration, and a growing suite of at-home diagnostics mean that your preventive medical care is evolving from one day a year to every day of the year.

We Have Come a Long Way in the Last Five Years

The wearable of five years ago was a glorified step counter. Today's devices are something closer to ambulatory diagnostic labs strapped to a wrist or slipped onto a finger in that they track heart rate variability, blood oxygen saturation, skin temperature, respiratory rate, sleep architecture, and — increasingly — blood pressure trends in real time. Plus at-home labs – including wearable phlebotomy – are adding another diagnostic tool to the toolbox. 

The data streams that these devices generate are orders of magnitude richer than anything captured during a routine office visit. 

From my perspective, two devices have emerged as the leading edge of this transformation: WHOOP and the Oura Ring.

A third – less well-known – device that I think is the next game-changer: an at-home phlebotomy device made by Rythm Health.  

WHOOP

WHOOP is an athlete's tool, built around the insight that recovery is as important as exertion. Its flagship metric — a daily "Recovery Score" synthesizing HRV, resting heart rate, and sleep performance — has become a staple for elite sports teams, military units, and now millions of everyday users. The company's latest hardware, the WHOOP MG, introduced Blood Pressure Insights (BPI), a feature that continuously monitors cardiovascular strain and presents color-coded readings to help users understand whether their blood pressure trends are within a healthy range. The company also quietly introduced an affiliated medical practice, Whoop Physician Services, P.C., allowing it to participate in the CMS ACCESS Program (discussed below).  

WHOOP's ambition is explicit: to deliver, in its own words, "medical-grade health and performance insights." That phrase drew scrutiny — and, in July 2025, a formal warning letter from the U.S. Food and Drug Administration.

*One cool feature about WHOOP: not only is the battery very long-lasting, but it also has an external charger that you can attach while still wearing the device. So, you do not need to remove the device to charge it, resulting in a truly uninterrupted data stream.

Oura Ring

The Oura Ring has carved a different path — elegant, unobtrusive, and increasingly clinical. The Oura Ring 5, unveiled in May 2026, brings formidable capabilities: Blood Pressure Signals that track cardiovascular patterns over 30-day rolling windows, a respiratory health pathway developed in partnership with ResMed, glucose integration through Dexcom's Stelo sensor, and, critically, a built-in telemedicine layer. Through a partnership with Counsel Health, Oura Ring 5 members in 43 states can now message licensed physicians directly within the Oura app — closing the loop between continuous biometric monitoring and clinical care. Oura has also partnered with Maven Clinic to integrate ring biometrics into virtual women's health journeys, supporting users from fertility tracking through postpartum recovery.

*As a caveat, I think that the Oura Ring is beautiful and my wife loves hers.  However, because it is a ring, I would not feel comfortable using it while weight-lifting as it could get damaged or injure my finger.  

The FDA is Clearly Finding it Difficult to Keep up. 

Regulatory clarity has not kept pace with technology, and the FDA's recent actions illustrate the challenges that regulators are facing. 

For example, in July 2025, the FDA sent WHOOP a formal warning letter concluding that its Blood Pressure Insights feature — with its color-coded range indicators, references to target blood pressure, and marketing language invoking "medical-grade" insights — crossed the line into uncleared medical device territory.

So what did WHOOP do in response? It was widely reported that it lobbied directly to RFK, Jr. (the head of the Department of Health and Human Services) for support. And it appears to have worked, as the FDA issued updated guidance in January 2026, greatly increasing regulatory clarity and flexibility around wearables.  

The 2026 General Wellness Policy Update

On January 6, 2026, the FDA finalized a significant update to its General Wellness: Policy for Low Risk Devices guidance. The updated framework attempts to define where the line sits between a wellness product — which the FDA generally does not regulate — and a medical device, which requires premarket authorization. The core test is intended use: what claims does a company make, explicitly or implicitly, through its labeling, advertising, features, and interface design?

Under the updated policy, non-invasive products that output physiologic parameters, including blood pressure estimates, can qualify as general wellness products if their intended use is clearly and consistently wellness-focused and their risk profile remains low. Non-invasive sensors such as sleep trackers and heart rate monitors are interpreted as low-risk wellness devices. Invasive devices remain subject to conventional regulatory pathways. 

The Missing Layer: Laboratory Data Enters the Home

Wearables capture what the body does continuously — movement, heart rate, sleep, temperature. But they cannot yet tell you what the body is — the underlying biochemistry that drives or predicts those signals. 

This is a big gap because if you are adjusting supplements, prescription drugs, or peptides, labs drawn on a regular cadence are critical in evaluating efficacy and effects on your body.

Interestingly, while the timing and nature of the January 6 FDA guidance looks like a win for WHOOP – and it is clearly a win for wearables in general, based on publicly available information, the July 2025 warning letter remains unresolved. According to a May 2026 STAT News article, the company engaged the FDA in ongoing discussions and submitted validation studies for the Blood Pressure Insights feature. The January 2026 general wellness guidance — which explicitly permits non-invasive blood pressure outputs for wellness purposes — is broadly seen as having narrowed the dispute, but it did not close WHOOP's enforcement file. The outcome will turn on whether WHOOP's marketing language and feature design can be reconciled with the guidance's core requirement: that such products make no claims to medical-grade accuracy and do not present clinical-grade values without independent validation.

That gap is now closing, thanks to a new generation of at-home laboratory testing services that are converging with wearable platforms to create a genuinely integrated picture of health. The logic is compelling. A wearable can detect that your HRV has been declining for three weeks and your resting heart rate is elevated. But is that stress, poor sleep, a thyroid issue, or a brewing inflammatory condition? Without bloodwork, a clinician is guessing. With a recent ApoB, hsCRP, TSH, and cortisol-adjacent hormones in hand, that same data suddenly tells a coherent story.

Rythm Health: Bringing the Blood Panel

Rythm Health is one of the most compelling examples of how at-home lab testing is evolving to complement wearable monitoring.  Rythm is a subscription-based service (advertised at $79/month) that ships a painless (I confirmed this myself) at-home blood collection kit directly to users in all 50 states. Users collect their sample at home and mail it back; results arrive within 72 hours via the Rythm app, processed by CLIA-certified, CAP-accredited laboratories.   According to the Rythm Health website, a single test covers five categories of biomarkers: hormone balance (estradiol, progesterone, testosterone, free testosterone), heart health (ApoB, LDL, HDL, hsCRP inflammation, hematocrit, hemoglobin), metabolic efficiency (ferritin, vitamin D, triglycerides, uric acid, fructosamine, ApoB/LDL particle size ratio), thyroid function (TSH, free T3), and liver and kidney markers (creatinine, SHBG, GGT, alkaline phosphatase). 

The results will fit neatly into my WHOOP app, in a better way than WHOOP’s own integrated solution, which would still require me to go to a lab facility for a blood draw.

*As of writing, I have not received my initial results yet. Last week I drew labs elsewhere, so I will be able to compare the fasted results for accuracy (recognizing that I am an N of 1). The redness around the device is from a round-shaped mini heating pad that they provide in the pack to increase blood flow before you begin the draw. It was not from irritation or a reaction to the device.   

The Broader Platform Convergence

Oura and WHOOP both have native integrations with telehealth to facilitate the ordering of labs and interpretations.  

Oura's Health Panels allows users to order blood tests directly within the Oura app, with results covering metabolic health, inflammation, thyroid function, and nutrient status — appearing in the same interface as their nightly recovery scores. WHOOP has similarly introduced laboratory panel integrations, combining physiologic sensor data with clinician-reviewed biochemical markers in a single report. Oura has also integrated directly with Dexcom's Stelo continuous glucose monitor, bridging real-time interstitial glucose data with the ring's existing metabolic and sleep insights.

The clear vision toward which all of these integrations point is a unified health dashboard: wearable biometrics updating continuously, laboratory biomarkers updating monthly, and AI layering correlations across both streams to surface patterns that neither data source could reveal alone. 

This seems obvious but nonetheless warrants reiterating: when a blood panel shows low testosterone and the WHOOP is showing poor sleep, high stress, and poor recoveries, the biometric signals now explain symptoms supported by actual medical data. They become a clinical signal — one that a telemedicine provider can act on.

Why Telemedicine Changes Everything

Consumer wearables alone are powerful. Connected to telemedicine platforms, they become transformational.

The traditional model of remote patient monitoring required clinical-grade devices — cuffs, patches, FDA-cleared sensors — prescribed by a physician and shipped to a patient's home. That kind of program can be expensive and feel cumbersome. The new model is inverted: tens of millions of people are already wearing sophisticated biosensors. The question is how to route that data meaningfully to clinicians.

That integration is now happening. Oura's partnership with Counsel Health embeds virtual physician access directly in the wearable's app. Maven Clinic is using Oura biometrics to support continuous virtual women's health care. Developer APIs from both WHOOP and Oura make it straightforward to integrate longitudinal biometric data into telehealth platforms, remote monitoring dashboards, and chronic disease management programs.

The downstream implications are substantial. A primary care physician conducting a video visit can, for the first time, arrive at that encounter with weeks of the patient's resting heart rate trends, sleep quality scores, HRV patterns, and a recent Rythm blood panel — data no office visit could ever generate in isolation. A cardiologist monitoring a patient recovering from a procedure can receive automated alerts when recovery metrics fall outside expected ranges, correlated against inflammation markers that a monthly at-home test provides. A mental health provider can correlate sleep fragmentation data from an Oura ring with mood and medication adherence in ways that were simply impossible before.

*While the data may not legally be “medical grade,” these trend lines can be really meaningful.  

The Road Ahead

The fusion of wearables and telemedicine is not a trend — it is a structural shift in how healthcare is delivered and experienced. Several forces will accelerate it in the years ahead.

Regulatory maturation is inevitable. The FDA's 2026 wellness guidance signals that the agency is engaging seriously with the challenge of classifying devices that sit at the intersection of consumer technology and medicine. Clearer standards, once established, will unlock more investment and faster clinical integration.  A consistent pathway, however, seems largely reliant on political continuity. Politics aside, it is a fact that the prior Administration’s FDA views and priorities were in many ways starkly different than the current Administration.

Reimbursement reform is the next frontier within the frontier. Payers — Medicare, Medicaid, and commercial insurers — are starting to see the value of wearables integration. See, for example, CMS’s ACCESS Model (Advancing Chronic Care with Effective, Scalable Solutions). ACCESS is a 10-year voluntary payment model launching July 2026 that pays physicians monthly to use tech-enabled tools — including wearables monitoring blood pressure, glucose, sleep, and movement — to manage chronic conditions. Over 150 providers and digital health firms have already been accepted. Targets conditions covering two-thirds of Medicare beneficiaries: hypertension, diabetes, chronic musculoskeletal pain, and depression.

AI-driven interpretation will make continuous biometric streams clinically actionable at scale. Raw HRV data means little to most patients and even many clinicians. AI models that translate continuous biosensor streams into clinical insights — flagging early signs of atrial fibrillation, predicting metabolic dysregulation, identifying sleep disorder patterns — are what close the loop between data and care.

The Bottom Line

The bottom line is this: the doctor's office is no longer the only place medicine happens. For millions of people, it is now happening continuously, on their wrist, on their finger, and increasingly, through their phones — connected to clinicians who can act on what the data reveals.  This is the next frontier.

This article is for informational purposes only and does not constitute legal advice. You should not act or refrain from acting based on any content included here without seeking appropriate legal counsel.